These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
489 related items for PubMed ID: 9698566
1. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions. Pisabarro MT, Serrano L, Wilmanns M. J Mol Biol; 1998 Aug 21; 281(3):513-21. PubMed ID: 9698566 [Abstract] [Full Text] [Related]
7. Structural studies of the phosphatidylinositol 3-kinase (PI3K) SH3 domain in complex with a peptide ligand: role of the anchor residue in ligand binding. Batra-Safferling R, Granzin J, Mödder S, Hoffmann S, Willbold D. Biol Chem; 2010 Jan 21; 391(1):33-42. PubMed ID: 19919182 [Abstract] [Full Text] [Related]
9. The crystal structure of the N-terminal SH3 domain of Grb2. Guruprasad L, Dhanaraj V, Timm D, Blundell TL, Gout I, Waterfield MD. J Mol Biol; 1995 May 12; 248(4):856-66. PubMed ID: 7752246 [Abstract] [Full Text] [Related]
10. The C-terminal SH3 domain of p67phox binds its natural ligand in a reverse orientation. Finan P, Koga H, Zvelebil MJ, Waterfield MD, Kellie S. J Mol Biol; 1996 Aug 16; 261(2):173-80. PubMed ID: 8757285 [Abstract] [Full Text] [Related]
11. Examining the specificity of Src homology 3 domain--ligand interactions with alkaline phosphatase fusion proteins. Yamabhai M, Kay BK. Anal Biochem; 1997 Apr 05; 247(1):143-51. PubMed ID: 9126384 [Abstract] [Full Text] [Related]
12. High-resolution structure of the diphtheria toxin repressor complexed with cobalt and manganese reveals an SH3-like third domain and suggests a possible role of phosphate as co-corepressor. Qiu X, Pohl E, Holmes RK, Hol WG. Biochemistry; 1996 Sep 24; 35(38):12292-302. PubMed ID: 8823163 [Abstract] [Full Text] [Related]
14. SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef. Hiipakka M, Poikonen K, Saksela K. J Mol Biol; 1999 Nov 12; 293(5):1097-106. PubMed ID: 10547288 [Abstract] [Full Text] [Related]
15. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. Nagar B, Hantschel O, Seeliger M, Davies JM, Weis WI, Superti-Furga G, Kuriyan J. Mol Cell; 2006 Mar 17; 21(6):787-98. PubMed ID: 16543148 [Abstract] [Full Text] [Related]
16. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation. Cowan-Jacob SW, Fendrich G, Manley PW, Jahnke W, Fabbro D, Liebetanz J, Meyer T. Structure; 2005 Jun 17; 13(6):861-71. PubMed ID: 15939018 [Abstract] [Full Text] [Related]
17. SH3 domains and drug design: ligands, structure, and biological function. Dalgarno DC, Botfield MC, Rickles RJ. Biopolymers; 1997 Jun 17; 43(5):383-400. PubMed ID: 9566119 [Abstract] [Full Text] [Related]
18. A miniprotein scaffold used to assemble the polyproline II binding epitope recognized by SH3 domains. Cobos ES, Pisabarro MT, Vega MC, Lacroix E, Serrano L, Ruiz-Sanz J, Martinez JC. J Mol Biol; 2004 Sep 03; 342(1):355-65. PubMed ID: 15313630 [Abstract] [Full Text] [Related]
19. Structural basis of PxxDY motif recognition in SH3 binding. Aitio O, Hellman M, Kesti T, Kleino I, Samuilova O, Pääkkönen K, Tossavainen H, Saksela K, Permi P. J Mol Biol; 2008 Sep 26; 382(1):167-78. PubMed ID: 18644376 [Abstract] [Full Text] [Related]